Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Mellis, MG; Oldroyd, B; Hind, K (2014)
Publisher: Nature Publishing Group
Languages: English
Types: Article

Classified by OpenAIRE into

mesheuropmc: nutritional and metabolic diseases
CoreScan is a new software for the GE Lunar iDXA, which provides a quantification of visceral adipose tissue (VAT). The objective of this study was to determine the in vivo precision of CoreScan for the measurement of VAT mass in a heterogeneous group of adults. Forty-five adults (aged 34.6 (8.6) years), ranging widely in body mass index (BMI 26.0 (5.2)  kg/m(2); 16.7-42.4 kg/m(2)), received two consecutive total body scans with repositioning. The sample was divided into two subgroups based on BMI, normal-weight and overweight/obese, for precision analyses. Subgroup analyses revealed that precision errors (RMSSD:%CV; root mean square standard deviation:% coefficient of variation) for VAT mass were 20.9 g:17.0% in the normal-weight group and 43.7 g:5.4% in overweight/obese groups. Our findings indicate that precision for DXA-VAT mass measurements increases with BMI, but caution should be used with %CV-derived precision error in normal BMI subjects.European Journal of Clinical Nutrition advance online publication, 15 October 2014; doi:10.1038/ejcn.2014.213.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Kishida K, Funahashi, T, Matsuzawa Y, Shimomura I. (2012) Visceral adiposity as a target for the management of the metabolic syndrome. Ann Med 2012; 44: 233-241.
    • 2. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity 2006; 14: 336-341.
    • 3. Hind K, Oldroyd B, Truscott J. In-vivo short term precision of the GE Lunar iDXA for the measurement of three compartment total body composition in adults. Eur J Clin Nutr 2011; 65: 140-142.
    • 4. Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity 2012l 20:1313-1318.
    • 5. Bland JM, Altman DG. Comparing two methods of clinical measurement: a personal history. Int J Epidemiol 1995; 24: S7-14.
    • 6. Rothney MP, Xia Y, Wacker WK, Martin FP, Beaumont M, Rezzi S et al. Precision of a new tool to measure visceral adipose tissue (VAT) using dual-energy X-ray absorptiometry (DXA). Obesity 2013; 21: E134-E138.
    • Fig 1 a
  • No related research data.
  • No similar publications.

Share - Bookmark

Download from

Cite this article